168 related articles for article (PubMed ID: 32744175)
1. ALDH3B1 Is an Independent Prognostic Biomarker of Lung Adenocarcinoma.
Sun H; Zhang M; Li L; Huang Z
Technol Cancer Res Treat; 2020; 19():1533033820946018. PubMed ID: 32744175
[TBL] [Abstract][Full Text] [Related]
2. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
3. [ALDH3B1 expression is correlated with histopathology and long-term prognosis of gastric cancer].
Li Q; Qiu Q; Zhang L; Zhang X; Wang Y; Geng Z; Ge S; Zuo L; Song X; Li J; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):633-640. PubMed ID: 35673905
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
5. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
7. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.
Hagiuda D; Nagashio R; Ichinoe M; Tsuchiya B; Igawa S; Naoki K; Satoh Y; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2019; 40(1):17-27. PubMed ID: 30787260
[TBL] [Abstract][Full Text] [Related]
9. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
10. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
Nagashio R; Kuchitsu Y; Igawa S; Kusuhara S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2020; 41(3):149-159. PubMed ID: 32522932
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
13. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
Guo T; Zhao S; Li Z; Li F; Li J; Gu C
Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
15. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
16. High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy.
Hai Y; Chen N; Wu W; Wang Z; Lin F; Guo C; Liu C; Li W; Liu L
BMC Cancer; 2018 Oct; 18(1):1011. PubMed ID: 30348119
[TBL] [Abstract][Full Text] [Related]
17. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
[TBL] [Abstract][Full Text] [Related]
18. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
19. The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma.
Qixing M; Juqing X; Yajing W; Gaochao D; Wenjie X; Run S; Anpeng W; Lin X; Feng J; Jun W
Tumour Biol; 2017 Apr; 39(4):1010428317698340. PubMed ID: 28381170
[TBL] [Abstract][Full Text] [Related]
20. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
Chen H; Tian X; Luan Y; Lu H
Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
